Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO
· Real-Time Price · USD
7.12
-0.11 (-1.52%)
At close: Aug 15, 2025, 3:59 PM
7.13
0.14%
After-hours: Aug 15, 2025, 06:57 PM EDT
Abeona Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | 2.82M | n/a | 3.5M | n/a | 68K | n/a | 1M | 346K | 3M | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | 1.67M | 724K | 721K | 369K | 838K | 888K | 100K | n/a | 350K | 1.11M | 1.2M | 1.08M | 1.1M | 1.08M |
Gross Profit | n/a | -776K | n/a | -224K | -724K | 1.41M | -369K | 2.66M | -8.04M | -32K | n/a | 650K | -767K | 1.8M | -9.06M | -8.53M | -8.32M |
Operating Income | -19.73M | -16.67M | -15.35M | -17.86M | -14.33M | -13.21M | -11.33M | -10.55M | -12.04M | -12.94M | -9.38M | -8.01M | -20.59M | -14.19M | -14.87M | -13.71M | -14.6M |
Interest Income | 1.31M | 1.02M | 1.19M | 1.19M | 843K | 743K | 593K | 417K | 364K | 328K | 72K | 31K | 7K | 36K | 10K | 8K | 15K |
Pretax Income | -12.03M | -9.29M | -30.27M | 7.41M | -31.58M | -16.59M | -11.84M | -16.65M | -9.11M | -1.13M | -9.48M | -4.1M | -20.79M | -46.68M | -7.04M | -15.21M | -16M |
Net Income | -12.03M | -9.29M | -30.27M | 7.41M | -31.58M | -16.59M | -11.84M | -16.65M | -9.11M | -1.13M | -9.48M | -4.1M | -22.04M | -46.68M | -7.04M | -15.21M | -16M |
Selling & General & Admin | 9.79M | 7.68M | 6.4M | 8.65M | 7.12M | 5.83M | 4.16M | 5.02M | 4M | 5.68M | 3.89M | 3.46M | 4.22M | 4.68M | 5.82M | 5.46M | 6.57M |
Research & Development | 9.94M | 8.99M | 8.94M | 9.22M | 7.21M | 7.38M | 7.15M | 8.52M | 8.04M | 6.27M | 5.49M | 6.66M | 10.54M | 11.7M | 9.09M | 7.43M | 7.21M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -888K | n/a | n/a | n/a | n/a | -389K | -831K | -275K | -268K |
Operating Expenses | 19.73M | 16.67M | 15.35M | 17.86M | 14.33M | 13.21M | 11.3M | 13.54M | 11.15M | 11.95M | 9.38M | 10.12M | 14.77M | 15.99M | 14.07M | 12.62M | 13.51M |
Interest Expense | 998K | 1.08M | 1.1M | 1.07M | 952K | 109K | 105K | 103K | 101K | 178K | 157K | 200K | 201K | 67K | 683K | 1.5M | 1.42M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 19.73M | 16.67M | 15.35M | 17.86M | 14.33M | 13.21M | 11.33M | 14.05M | 12.04M | 12.05M | 9.38M | 10.47M | 14.77M | 17.19M | 14.87M | 13.71M | 14.6M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 200K | 67K | n/a | 8K | 15K |
Shares Outstanding (Basic) | 49.78M | 41.05M | 48.08M | 40.01M | 27.32M | 25.56M | 24.8M | 18.02M | 16.9M | 7.14M | 6.42M | 5.81M | 5.79M | 4.19M | 3.92M | 3.87M | 3.77M |
Shares Outstanding (Diluted) | 49.78M | 41.05M | 48.08M | 51.23M | 27.32M | 25.56M | 24.8M | 18.02M | 16.9M | 7.14M | 6.42M | 5.81M | 5.79M | 4.19M | 3.92M | 3.87M | 3.77M |
EPS (Basic) | -0.24 | -0.23 | -0.63 | 0.19 | -1.16 | -0.65 | -0.48 | -0.92 | -0.54 | -0.53 | -1 | -1.36 | -3.8 | -11.15 | -1.8 | -3.93 | -4.25 |
EPS (Diluted) | -0.24 | -0.23 | -0.63 | 0.14 | -1.16 | -0.65 | -0.48 | -0.92 | -0.54 | -0.53 | -1 | -1.36 | -3.8 | -11.15 | -1.8 | -3.93 | -4.25 |
EBITDA | -10.22M | -7.43M | -28.45M | 9.16M | -29.9M | -15.76M | -10.98M | -15.71M | -8.12M | 61K | -8.24M | -6.61M | -20.59M | -45.42M | -5.28M | -12.61M | -13.5M |
EBIT | -11.03M | -8.21M | -29.17M | 8.48M | -30.63M | -16.48M | -11.73M | -16.55M | -9.01M | -948K | -9.33M | -7.98M | -20.59M | -46.62M | -6.36M | -13.71M | -14.58M |
Depreciation & Amortization | 815K | 776K | 722K | 685K | 724K | 721K | 751K | 838K | 888K | 1.01M | 1.08M | 1.37M | 1.11M | 1.2M | 1.08M | 1.1M | 1.08M |